$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

$cpix Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000162828021004654 Filed on March 12, 2021

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$9.306M	$6.935M	$9.417M
YoY Change	-11.27%	18.48%	32.92%
Cost Of Revenue	$2.390M	$1.581M	$1.792M
YoY Change	58.28%	8.23%	17.66%
Gross Profit	$6.920M	$5.355M	$7.625M
YoY Change	1053.33%	21.89%	37.11%
Gross Profit Margin	74.36%	77.21%	80.97%
Selling, General & Admin	$7.180M	$5.845M	$6.253M
YoY Change	150.17%	-14.94%	-15.62%
% of Gross Profit	103.76%	109.15%	82.0%
Research & Development	$2.080M	$1.673M	$1.716M
YoY Change	-29.25%	28.08%	18.32%
% of Gross Profit	30.06%	31.24%	22.51%
Depreciation & Amortization	$1.120M	$1.110M	$1.090M
YoY Change	28.74%	54.17%	55.71%
% of Gross Profit	16.18%	20.73%	14.29%
Operating Expenses	$10.31M	$7.517M	$7.969M
YoY Change	55.27%	-8.07%	-10.07%
Operating Profit	-$3.394M	-$3.196M	-$1.373M
YoY Change	3.07%	20.87%	-28.44%
Interest Expense	$20.00K	$64.88K	$91.20K
YoY Change	-33.33%	237.92%	314.19%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.380M	-$3.312M	-$1.334M
YoY Change	-43.85%	99.52%	79.96%
Income Tax	-$10.00K	$4.462K	$4.462K
% Of Pretax Income
Net Earnings	-$960.7K	-$1.954M	-$549.5K
YoY Change	-56.73%	18.91%	-23.75%
Net Earnings / Revenue	-10.32%	-28.17%	-5.83%
Basic Earnings Per Share	-$0.06	-$0.13	-$0.04
Diluted Earnings Per Share	-$0.06	-$0.13	-$0.04
COMMON SHARES
Basic Shares Outstanding	15.18M shares	15.37M shares	15.52M shares
Diluted Shares Outstanding		15.37M shares	15.52M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.20M	$29.24M	$30.43M
YoY Change	-22.16%	-38.81%	-39.98%
Cash & Equivalents	$28.21M	$26.98M	$20.95M
Short-Term Investments	$0.00	$2.266M	$9.480M
Other Short-Term Assets	$2.757M	$1.992M	$2.425M
YoY Change	-6.96%	-15.28%	-13.38%
Inventory	$8.871M	$9.864M	$10.65M
Prepaid Expenses
Receivables	$7.859M	$8.297M	$8.427M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$50.16M	$49.40M	$51.93M
YoY Change	-15.14%	-22.36%	-22.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$747.8K	$743.8K	$737.2K
YoY Change	-3.04%	37.99%	22.87%
Goodwill	$882.0K	$882.0K	$882.0K
YoY Change	12.5%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.299M	$6.329M	$6.066M
YoY Change	30.32%	125.28%	133.3%
Total Long-Term Assets	$54.39M	$54.37M	$55.61M
YoY Change	1.51%	128.38%	133.67%
TOTAL ASSETS
Total Short-Term Assets	$50.16M	$49.40M	$51.93M
Total Long-Term Assets	$54.39M	$54.37M	$55.61M
Total Assets	$104.5M	$103.8M	$107.5M
YoY Change	-7.23%	18.68%	18.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.994M	$8.227M	$9.540M
YoY Change	21.71%	-2.61%	-5.54%
Accrued Expenses	$11.08M	$900.0K	$900.0K
YoY Change	-30.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$24.15M	$21.05M	$22.32M
YoY Change	-13.14%	35.67%	32.84%
LONG-TERM LIABILITIES
Long-Term Debt	$18.50M	$20.00M	$20.00M
YoY Change	-7.5%	66.67%	66.67%
Other Long-Term Liabilities	$8.737M	$11.00M	$11.50M
YoY Change	-6.24%	450.0%	475.0%
Total Long-Term Liabilities	$8.737M	$31.00M	$31.50M
YoY Change	-6.24%	121.43%	125.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.15M	$21.05M	$22.32M
Total Long-Term Liabilities	$8.737M	$31.00M	$31.50M
Total Liabilities	$53.46M	$52.06M	$53.86M
YoY Change	-6.41%	76.55%	76.58%
SHAREHOLDERS EQUITY
Retained Earnings	$1.208M	$2.169M	$4.123M
YoY Change	-74.54%	-68.86%
Common Stock	$49.91M	$49.56M	$49.94M
YoY Change	-2.32%	-3.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$51.12M	$51.73M	$54.06M
YoY Change
Total Liabilities & Shareholders Equity	$104.5M	$103.8M	$107.5M
YoY Change	-7.23%	18.68%	18.97%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	-$960.7K	-$1.954M	-$549.5K
YoY Change	-56.73%	18.91%	-23.75%
Depreciation, Depletion And Amortization	$1.120M	$1.110M	$1.090M
YoY Change	28.74%	54.17%	55.71%
Cash From Operating Activities	$860.0K	$740.0K	$1.850M
YoY Change	-76.88%	-145.12%	134.18%
INVESTING ACTIVITIES
Capital Expenditures	-$360.0K	-$180.0K	-$90.00K
YoY Change	-86.67%	-79.07%	0.0%
Acquisitions
YoY Change
Other Investing Activities	$2.260M	$7.120M	-$4.730M
YoY Change	-112.07%	34.85%	-637.5%
Cash From Investing Activities	$1.910M	$6.940M	-$4.830M
YoY Change	-108.92%	56.66%	-719.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.530M	-1.640M	-690.0K
YoY Change	-120.76%	281.4%	-26.6%
NET CHANGE
Cash From Operating Activities	860.0K	740.0K	1.850M
Cash From Investing Activities	1.910M	6.940M	-4.830M
Cash From Financing Activities	-1.530M	-1.640M	-690.0K
Net Change In Cash	1.240M	6.040M	-3.670M
YoY Change	-112.02%	155.93%	-682.54%
FREE CASH FLOW
Cash From Operating Activities	$860.0K	$740.0K	$1.850M
Capital Expenditures	-$360.0K	-$180.0K	-$90.00K
Free Cash Flow	$1.220M	$920.0K	$1.940M
YoY Change	-81.0%	-217.95%	120.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001087294
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	cpix	Financial Consideration Payment Period FinancialConsiderationPaymentPeriod	P2Y
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Entity Registrant Name EntityRegistrantName	CUMBERLAND PHARMACEUTICALS INC
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TN
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1765329
CY2020	dei	Entity File Number EntityFileNumber	001-33637
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	2525 West End Avenue
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 950
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37203
CY2020	dei	City Area Code CityAreaCode	615
CY2020	dei	Local Phone Number LocalPhoneNumber	255-0068
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.00 par value per share
CY2020	dei	Trading Symbol TradingSymbol	CPIX
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q2	dei	Entity Public Float EntityPublicFloat	30639333	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14920655	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24753796	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28212635	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12377713	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7859006	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10638157	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	8871254	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2199926	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2757456	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2019Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2462724	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	49969592	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	50163075	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	11656742	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	15554992	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	574169	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	747796	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28118316	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30920324	USD
CY2020Q4	us-gaap	Goodwill Goodwill	882000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	882000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	21802	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2028148	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2960569	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3234338	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3298725	USD
CY2020Q4	us-gaap	Assets Assets	96463305	USD
CY2019Q4	us-gaap	Assets Assets	104549283	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13396286	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9993578	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1016779	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	920431	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	-37620	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11254381	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11084869	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2151357	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25667446	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24150235	USD
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15000000	USD
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	18500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1059693	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2076472	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7862772	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8737323	USD
CY2020Q4	us-gaap	Liabilities Liabilities	49589911	USD
CY2019Q4	us-gaap	Liabilities Liabilities	53464030	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14988429	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14988429	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15263555	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15263555	shares
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	49121523	USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	49914478	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2131013	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1208395	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	46990510	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	51122873	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-117116	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10196299	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9974384	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46873394	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51085253	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96463305	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104549283	USD
CY2020	us-gaap	Revenues Revenues	37441134	USD
CY2019	us-gaap	Revenues Revenues	34388295	USD
CY2018	us-gaap	Revenues Revenues	29344894	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8653020	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7421316	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6016822	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14765465	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15277740	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14004933	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5773825	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6868480	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7575892	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10150777	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4434120	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4134557	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2769466	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	43822729	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	43676477	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	40517890	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-6381595	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-9288182	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-11172996	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	75345	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	243364	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	564484	USD
CY2020	us-gaap	Interest Expense InterestExpense	263627	USD
CY2019	us-gaap	Interest Expense InterestExpense	246186	USD
CY2018	us-gaap	Interest Expense InterestExpense	195848	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6569877	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9291004	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10804360	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55902	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-79316	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16636	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6625779	USD
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-9211688	USD
CY2018	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10820996	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3206875	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	5665177	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3782224	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3418904	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-3546511	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79496	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8752	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-75704	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3339408	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-3537759	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6963068	USD
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.43
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.60
CY2018	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.69
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.21
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.37
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.24
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.43
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.60
CY2018	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.69
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.21
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.37
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.24
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15162184	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15396098	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15614052	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15162184	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15396098	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15614052	shares
CY2020	us-gaap	Profit Loss ProfitLoss	-3418904	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-3546511	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3206875	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	5665177	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3782224	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6625779	USD
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-9211688	USD
CY2018	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10820996	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4748565	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4404175	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2982703	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21802	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	65408	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	81886	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1046516	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1485898	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1364698	USD
CY2020	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2019	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2018	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	81886	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	1160202	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	804167	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0	USD
CY2020	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	440091	USD
CY2019	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
CY2018	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	47636	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	47525	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	99883	USD
CY2020	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	0	USD
CY2019	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	26315	USD
CY2018	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	168440	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4518707	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1399012	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	47288	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2131347	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1106175	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-528153	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1210489	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	615199	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-676750	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6569002	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3221780	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4153287	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1859330	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-729820	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-159558	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1896819	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2455240	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1390808	USD
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	3518242	USD
CY2019	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	5511596	USD
CY2018	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	4503545	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5415061	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3056356	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3112737	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	140817	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	246202	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	455569	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1973110	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	772944	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3819486	USD
CY2020	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	460888	USD
CY2019	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2018	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	5000000	USD
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	20000000	USD
CY2020	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2019	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	20062132	USD
CY2018	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	16122376	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	11745138	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	19572139	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1757789	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2297848	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27724818	USD
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	59000000	USD
CY2019	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	76000000	USD
CY2018	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	56000000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	62500000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	77500000	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	45800000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	200909	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1851526	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3494921	USD
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2879426	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	819180	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1033108	USD
CY2018	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	800000	USD
CY2017	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2016	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1000000	USD
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	135405	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	383310	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	10000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	52500	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7116111	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5080529	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7138173	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3458839	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	273675	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17473908	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28212635	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27938960	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45412868	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24753796	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28212635	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27938960	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	215991	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	198661	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	95965	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-91486	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	16694	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	15441	USD
CY2020	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-340997	USD
CY2019	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-576837	USD
CY2018	cpix	Purchases Of Intangible Assets Incurred But Not Yet Paid PurchasesOfIntangibleAssetsIncurredButNotYetPaid	-539467	USD
CY2020	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	200000	USD
CY2019	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	0	USD
CY2018	cpix	Deferred Offering Costs Includedin Accounts Payableand Other Accrued Expenses DeferredOfferingCostsIncludedinAccountsPayableandOtherAccruedExpenses	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	14034000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3629320	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020	cpix	Noncash Or Part Noncash Transaction Vesting Of Shares NoncashOrPartNoncashTransactionVestingOfShares	0	USD
CY2019	cpix	Noncash Or Part Noncash Transaction Vesting Of Shares NoncashOrPartNoncashTransactionVestingOfShares	862200	USD
CY2018	cpix	Noncash Or Part Noncash Transaction Vesting Of Shares NoncashOrPartNoncashTransactionVestingOfShares	0	USD
CY2020	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	USD
CY2019	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	800000	USD
CY2018	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	148000	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63921601	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1364698	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200909	USD
CY2018	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2877935	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	55570501	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-3546511	USD
CY2019	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	800000	USD
CY2019	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1000000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	862200	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1485898	USD
CY2019	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3486835	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	51085253	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3418904	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1046516	USD
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1839471	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46873394	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79496	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8752	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-75704	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions.
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	400000	USD
CY2020	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	890686	USD
CY2019	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	613637	USD
CY2018	us-gaap	Production And Distribution Costs ProductionAndDistributionCosts	457814	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	2379424	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	2594630	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	2005113	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3300000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4900000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35840673	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32407845	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28803961	USD
CY2020	cpix	Revenue Recognition Upfront Payment RevenueRecognitionUpfrontPayment	1000000.0	USD
CY2020	cpix	Revenue Recognition Potential Upfront Payments Relatedto Regulatory Approval RevenueRecognitionPotentialUpfrontPaymentsRelatedtoRegulatoryApproval	2200000	USD
CY2020	cpix	Revenue Recognition Potential Upfront Payment Relatedto Product Sales RevenueRecognitionPotentialUpfrontPaymentRelatedtoProductSales	4800000	USD
CY2020	cpix	Revenue Recognition Cumulative Upfront Payment RevenueRecognitionCumulativeUpfrontPayment	1200000	USD
CY2020	cpix	Revenue Recognition Milestone Payments RevenueRecognitionMilestonePayments	100000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16223162	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19345723	USD
CY2020Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	128005	USD
CY2019Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	416468	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5943732	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4664055	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	24426246	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	11656742	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	22294899	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	15554992	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10638157	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	8871254	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	200000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	15600000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4131256	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4142125	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3557087	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3394329	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	574169	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	747796	USD
CY2020	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	314444	USD
CY2019	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	269619	USD
CY2018	cpix	Depreciation Including Amortization Related To Leasehold Improvements DepreciationIncludingAmortizationRelatedToLeaseholdImprovements	213237	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28118316	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30920324	USD
CY2020Q4	us-gaap	Goodwill Goodwill	882000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	882000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4434120	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4134557	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2769466	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4338247	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3691293	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3629001	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3629001	USD
CY2020Q4	cpix	Finite Lived Intangible Assets Amortization Expense Year Fiveand After FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveandAfter	12830774	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28118316	USD
CY2020Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	4072151	USD
CY2019Q4	cpix	Product Sales Related Liabilities Current ProductSalesRelatedLiabilitiesCurrent	4593167	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	998064	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1295905	USD
CY2020Q4	cpix	Business Combination Contingent Consideration Liability Accrued Current BusinessCombinationContingentConsiderationLiabilityAccruedCurrent	2787741	USD
CY2019Q4	cpix	Business Combination Contingent Consideration Liability Accrued Current BusinessCombinationContingentConsiderationLiabilityAccruedCurrent	2374776	USD
CY2020Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	294000	USD
CY2019Q4	cpix	Accrued Liabilities Inventory Purchases AccruedLiabilitiesInventoryPurchases	829047	USD
CY2020Q4	cpix	Accrued Payment For Asset Purchase Current AccruedPaymentForAssetPurchaseCurrent	0	USD
CY2019Q4	cpix	Accrued Payment For Asset Purchase Current AccruedPaymentForAssetPurchaseCurrent	1000000	USD
CY2020Q4	cpix	Deferred Acquisition Liability Current DeferredAcquisitionLiabilityCurrent	2187140	USD
CY2019Q4	cpix	Deferred Acquisition Liability Current DeferredAcquisitionLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	915285	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	991974	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11254381	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11084869	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4855363	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	6258813	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2702772	USD
CY2019Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2278164	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	304637	USD
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	200346	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7862772	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8737323	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3206875	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	5665177	USD
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	cpix	Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities	100000000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	200000	USD
CY2020Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	6200000	USD
CY2019Q2	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	1000000	USD
CY2014Q2	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	300000	USD
CY2014Q2	cpix	Loans Forgivenin Exchange For Share Issued Amount LoansForgiveninExchangeForShareIssuedAmount	700000	USD
CY2019	cpix	Sharebased Compensation Charitable Contributionof Shares Shares SharebasedCompensationCharitableContributionofSharesShares	50000	shares
CY2020	cpix	Share Based Compensation Charitable Contribution Of Shares Committed Cash Contributions ShareBasedCompensationCharitableContributionOfSharesCommittedCashContributions	50000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6625779	USD
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-9211688	USD
CY2018	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10820996	USD
CY2018	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3782224	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-3418904	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-3546511	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-7038772	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-79496	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8752	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-75704	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3339408	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-3537759	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-6963068	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15162184	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15396098	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15614052	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15162184	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15396098	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15614052	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	197610	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41650	shares
CY2020Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	16961650	USD
CY2019Q4	cpix	Deferred Tax Assets Operating Loss Carryforwards And Tax Credit Carryforwards DeferredTaxAssetsOperatingLossCarryforwardsAndTaxCreditCarryforwards	16964685	USD
CY2020Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	227056	USD
CY2019Q4	cpix	Deferred Tax Assets Property And Equipment And Intangibles DeferredTaxAssetsPropertyAndEquipmentAndIntangibles	227072	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	249483	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	257564	USD
CY2020Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	438235	USD
CY2019Q4	cpix	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves For Expired Product DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReservesForExpiredProduct	469466	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	100362	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	35227	USD
CY2020Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	952711	USD
CY2019Q4	cpix	Deferred Tax Assets Deferred Charges DeferredTaxAssetsDeferredCharges	845765	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	928638	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1047149	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19858135	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19846928	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	662014	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1313965	USD
CY2020Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	19196121	USD
CY2019Q4	cpix	Net Deferred Tax Assets Gross NetDeferredTaxAssetsGross	18532963	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19196121	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18511161	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	21802	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-21802	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-65408	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	55902	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-79316	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	16636	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	34100	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-144724	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16636	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21802	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	65408	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	21802	USD
CY2019	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	65408	USD
CY2018	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55902	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-79316	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16636	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.06
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.07
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.23
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.31
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.25
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.07
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.01
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.03
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2020	cpix	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans Available For Future Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlansAvailableForFutureGrants	2	plan
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1700000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M10D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5800	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.00
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M24D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	5800	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.00
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2020	cpix	Defined Contribution Plan Eligibility Minimum Employee Age DefinedContributionPlanEligibilityMinimumEmployeeAge	P21Y
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3.6	USD
CY2020	cpix	Defined Contribution Plan Eligibility Minimum Employee Service Time For Participation Eligibility DefinedContributionPlanEligibilityMinimumEmployeeServiceTimeForParticipationEligibility	six months
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	50000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	2700000	USD
CY2019Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	2300000	USD
CY2020Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	2900000	USD
CY2019Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	3100000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1166411	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1246143	USD
CY2018	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1136610	USD
CY2020	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	680627	USD
CY2019	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	688020	USD
CY2018	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	662358	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3.8	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0742
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2028148	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2960569	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1016779	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	920431	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1059693	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2076472	USD
CY2020Q4	cpix	Lease Liability LeaseLiability	2076472	USD
CY2019Q4	cpix	Lease Liability LeaseLiability	2996903	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	400000	USD
CY2019	us-gaap	Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset	5000000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1144889	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1019313	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	92478	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2256680	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	180208	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2076472	USD
CY2020Q4	us-gaap	Trading Securities TradingSecurities	0	USD
CY2019Q4	us-gaap	Trading Securities TradingSecurities	2119607	USD
CY2020	us-gaap	Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset	3000000.0	USD
CY2020	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	3206875	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	13145344	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	11396871	USD
CY2020	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	0	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	1330704	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	1361273	USD
CY2020	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	0	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	6149463	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	6253374	USD
CY2020	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	3206875	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	5665177	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	3782224	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	1922457	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory1 DisposalGroupIncludingDiscontinuedOperationInventory1	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory1 DisposalGroupIncludingDiscontinuedOperationInventory1	540267	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2019Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2462724	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	1918868	USD
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	0	USD
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	232489	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2019Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2151357	USD
CY2020Q1	us-gaap	Revenues Revenues	8330734	USD
CY2020Q2	us-gaap	Revenues Revenues	9598177	USD
CY2020Q3	us-gaap	Revenues Revenues	9250689	USD
CY2020Q4	us-gaap	Revenues Revenues	10261534	USD
CY2020	us-gaap	Revenues Revenues	37441134	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1846001	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1580962	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1208686	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1745946	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-6381595	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1883418	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1679211	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1275620	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1787530	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6625779	USD
CY2020Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	818273	USD
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	738622	USD
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	777916	USD
CY2020Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	872064	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3206875	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1055620	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-918275	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-481737	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-883776	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3339408	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.11
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.43
CY2020Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2020Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.06
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.21
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2020Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.11
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.43
CY2020Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2020Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2020Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.06
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.21
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2019Q1	us-gaap	Revenues Revenues	8729860	USD
CY2019Q2	us-gaap	Revenues Revenues	9417443	USD
CY2019Q3	us-gaap	Revenues Revenues	6935439	USD
CY2019Q4	us-gaap	Revenues Revenues	9305553	USD
CY2019	us-gaap	Revenues Revenues	34388295	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1323932	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1373424	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3196436	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3394390	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-9288182	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1187553	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1338521	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3316286	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3369329	USD
CY2019	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-9211688	USD
CY2019Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1147136	USD
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	771709	USD
CY2019Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1349351	USD
CY2019Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2396981	USD
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	5665177	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-73878	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-549507	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1953668	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-960706	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-3537759	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.22
CY2019Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.22
CY2019	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.60
CY2019Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.08
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2019Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.09
CY2019Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.16
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.37
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2019Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2019Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2019Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.22
CY2019Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.22
CY2019	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.60
CY2019Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.08
CY2019Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2019Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.09
CY2019Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.16
CY2019	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.37
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23

Files In Submission

Name	View Source	Status
0001628280-21-004654-index-headers.html	Edgar Link	pending
0001628280-21-004654-index.html	Edgar Link	pending
0001628280-21-004654.txt	Edgar Link	pending
0001628280-21-004654-xbrl.zip	Edgar Link	pending
a2020-10kxex1011ajkazimi.htm	Edgar Link	pending
a2020-10kxex1013leopavliv.htm	Edgar Link	pending
a2020-10kxex1015jimherman.htm	Edgar Link	pending
a2020-10kxexhibit311.htm	Edgar Link	pending
a2020-10kxexhibit312.htm	Edgar Link	pending
a2020-10kxexhibit321.htm	Edgar Link	pending
a2020-xex1012martincearnal.htm	Edgar Link	pending
a2020-xex1014michaelbonner.htm	Edgar Link	pending
a2020-xex231consentofbdollp.htm	Edgar Link	pending
a2020-xex232consentofbkdllp.htm	Edgar Link	pending
a2020q4exhibit411.htm	Edgar Link	pending
cpix-20201231.htm	Edgar Link	pending
cpix-20201231.xsd	Edgar Link	pending
cpix-20201231_cal.xml	Edgar Link	unprocessable
cpix-20201231_def.xml	Edgar Link	unprocessable
cpix-20201231_g1.jpg	Edgar Link	pending
cpix-20201231_htm.xml	Edgar Link	completed
cpix-20201231_lab.xml	Edgar Link	unprocessable
cpix-20201231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2019 Q4 Form 10-K Financial Statement

#000162828021004654 Filed on March 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX CUMBERLAND PHARMACEUTICALS INC Stock $cpix

2019 Q4 Form 10-K Financial Statement

#000162828021004654 Filed on March 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPIX
CUMBERLAND PHARMACEUTICALS INC Stock $cpix